Abiraterone Acetate

specific

A substance being studied in the treatment of prostate cancer and breast cancer. It blocks tissues from making androgens (male hormones), such as testosterone. This may cause the death of cancer cells that need androgens to grow. It is a type of anti-androgen.

19

Centers

13

Active Trials

$18M

Cancer Funding

Top Centers for Abiraterone Acetate(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
54.2
2
NCI Comprehensive
Active Research Program
54.2
3
NCI Comprehensive
Active Research Program
54.2
4
NCI Comprehensive
Active Research Program
54.2
5
NCI Clinical
Active Research Program
54.2
6
NCI Comprehensive
Active Research Program
54.2
7
Active Research Program
54.2
8
Active Research Program
54.2
954.2
10
Active Research Program
54.2
11
Active Research Program
54.2
12
Active Research Program
54.2
13
Active Research Program
54.2
14
NCI Comprehensive
Active Research Program
53.8
15
NCI Comprehensive
Active Research Program
52.0
16
NCI Comprehensive
Active Research Program
50.1
17
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
48.3
18
NCI Comprehensive
Active Research Program
46.4
19
NCI Comprehensive
Active Research Program
44.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →